No evidence of horizontal infection in horses kept in close contact with dogs experimentally infected with canine influenza A virus (H3N8) by Takashi Yamanaka et al.
Yamanaka et al. Acta Veterinaria Scandinavica 2012, 54:25
http://www.actavetscand.com/content/54/1/25RESEARCH Open AccessNo evidence of horizontal infection in horses kept
in close contact with dogs experimentally
infected with canine influenza A virus (H3N8)
Takashi Yamanaka1*, Manabu Nemoto1, Hiroshi Bannai1, Koji Tsujimura1, Takashi Kondo1, Tomio Matsumura1,
Masanori Muranaka1, Takanori Ueno1, Yuta Kinoshita1, Hidekazu Niwa1, Kazuya IPJ Hidari2 and Takashi Suzuki2Abstract
Background: Since equine influenza A virus (H3N8) was transmitted to dogs in the United States in 2004, the
causative virus, which is called canine influenza A virus (CIV), has become widespread in dogs. To date, it has
remained unclear whether or not CIV-infected dogs could transmit CIV to horses. To address this, we tested
whether or not close contact between horses and dogs experimentally infected with CIV would result in its
interspecies transmission.
Methods: Three pairs of animals consisting of a dog inoculated with CIV (108.3 egg infectious dose50/dog) and a
healthy horse were kept together in individual stalls for 15 consecutive days. During the study, all the dogs and
horses were clinically observed. Virus titres in nasal swab extracts and serological responses were also evaluated. In
addition, all the animals were subjected to a gross pathological examination after euthanasia.
Results: All three dogs inoculated with CIV exhibited clinical signs including, pyrexia, cough, nasal discharge, virus
shedding and seroconversion. Gross pathology revealed lung consolidations in all the dogs, and Streptococcus equi
subsp. zooepidemicus was isolated from the lesions. Meanwhile, none of the paired horses showed any clinical signs,
virus shedding or seroconversion. Moreover, gross pathology revealed no lesions in the respiratory tracts including
the lungs of the horses.
Conclusions: These findings may indicate that a single dog infected with CIV is not sufficient to constitute a source
of CIV infection in horses.
Keywords: Canine influenza, Dog, H3N8, Horse, Interspecies transmissionInfluenza A viruses have been isolated from a wide variety
of animals, including humans, pigs, sea mammals, horses,
poultry and aquatic birds. It is well known that aquatic
birds serve as a natural reservoir from which all influenza
A viruses have emerged [1]. It has generally been accepted
that equine influenza A virus (EIV) subtype H3N8, which
was first isolated from a diseased horse in Florida in the
United States in 1963 [2], was also introduced into horses
from aquatic birds [1]. EIV infection in a horse produces
an acute respiratory disease [3]. EIV can have a profound
economic impact on the horse industry causing a major* Correspondence: yamanaka@epizoo.equinst.go.jp
1Epizootic Research Center, Equine Research Institute, the Japan Racing
Association, 1400-4 Shiba, Shimotsuke, Tochigi 329-0412, Japan
Full list of author information is available at the end of the article
© 2012 Yamanaka et al; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the ordisruption to horse racing and breeding because of its
rapid spread. Thus, EIV still poses a significant threat to
the equine industry [4].
Until recently dogs were not considered susceptible hosts
of influenza A viruses [5]. However, there was an outbreak
of respiratory disease among greyhounds in Florida in the
United States at the beginning of 2004 [6]. A subsequent
analysis of the causative virus revealed that the outbreak
resulted from an interspecies transmission of contemporary
EIV subtype H3N8 into dogs. After the outbreak in 2004,
the causative virus, which came to be called canine influ-
enza A virus (CIV), spread rapidly among dogs and prob-
ably became enzootic, at least in the United States [7,8].
Because CIV is genetically close to the ancestral form
of EIV [6], it has been intriguing to learn whether CIV-ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the H3N8 influenza A virus to the horse population. We
previously demonstrated that the CIV A/canine/Colorado/
30604/2006 (CO06) strain reduced proliferation ability and
pathogenicity in horses compared with EIV, although
CO06 (108.3 egg infectious dose50/dog) is still infectious to
horses via experimental inoculation using an ultrasonic
nebulizer connected to a facemask [9]. All three horses
exhibited seroconversion to CO06. Moreover, one of the
three experimental horses shed live virus from the nostrils.
Quintana et al. [10] also reported that the CIV-specific
gene was detected in nasal swabs collected from one pony
experimentally inoculated with CIV via aerosol inhalation.
However, the experimental inoculation with the ultrasonic
nebulizer seems unlikely to parallel natural infection in the
field. Therefore, it remains unclear whether or not CIV-
infected dogs could be the source of the H3N8 influenza A
virus infection found in horses in the field. To address this,
we undertook research to determine whether close contact
between a CIV-infected dog and a horse could cause the
interspecies transmission of CIV.
Materials and methods
Three dogs (beagles, 11 months old) and three Thorough-
bred horses (18–19 months old) were studied. All the ani-
mals were healthy and showed no serological evidence of
prior H3N8 virus infection or vaccination in haemagglu-
tination inhibition (HI) tests (HI titres <10) for antibodies
to CO06 and EIV (A/equine/Ibaraki/1/2007, H3N8) (See
below). CO06 was isolated from a diseased dog showing
an acute respiratory sign in the United States. Each dog
was randomly paired with a horse giving a total of three
pairs. The dogs were inoculated with CO06 [108.3 50% egg
infective doses (EID50)] by inhalation using an ultrasonic
nebulizer (Soniclizer305, ATOM, Tokyo, Japan) connected
to a facemask on Day 0 under sedation by intramuscular
administration of medetomidine hydrochloride (10 μg/kg
bodyweight; Domitor, Zenoaq, Fukushima, Japan).
Each pair remained in the same stall (3 m wide,
6.05 m deep and 4.1 m high) continuously from Day 0
to Day 14 as previously reported [11]. On Day 14, the
dogs were euthanized. From Days 15 to 21, each horse
was kept alone in the same stall. The rectal tempera-
tures of all the animals were measured each morning
during the experiment. A dog and a horse with rectal
temperatures exceeding 39.5 and 38.8°C, respectively,
were defined as having significant pyrexia in this study.
We performed daily physical observations of the dogs
and horses from Days −1 to 14 and from Days −1 to 21,
respectively. The observation records for each animal
were assigned scores as previously described by Jirjis
et al. [12] and Toulemonde et al. [13] with slight modifi-
cations (Table 1). We calculated the total clinical scores
for each animal each day.Nasal samples were collected from the dogs using
3.0 × 6.0 mm absorbent cotton swabs (1P1501, JCB In-
dustry, Tokyo, Japan) and from the horses using
1.0 × 1.5 cm absorbent cotton swabs (JMS menbou, Japan
Medical Supply, Hiroshima, Japan) on a daily basis (from
Days -1 to 14 and Days -1 to 21, respectively) and their
extracts were titrated in 10-day-old embryonated hen’s
eggs as previously described [11]. Briefly, the swabs col-
lected from the horses and the dogs were immersed in
2.5 and 1.0 ml of transport medium [phosphate buffered
saline (PBS, pH 7.2) supplemented with 0.6% tryptose
phosphate broth, 500 unit/ml penicillin, 500 μg/ml
streptomycin and 1.25 μg/ml amphotericin B), respect-
ively. The swab samples in the transport medium were
vortexed and briefly centrifuged to precipitate debris.
Then, 200 μl of the supernatants that had been diluted
at 1:10 (v/v) in transport medium were injected into the
allantoic cavities of embryonated hen’s eggs (four eggs
per sample). The allantoic fluid was harvested after 3 days
of incubation at 34.0°C and examined for the presence of
influenza A virus in a hemagglutination test using 0.5%
hen’s red blood cells. The virus titres (log10EID50
/200 μl) were determined for nasal swab samples that
were haemagglutination-positive [14].
The HI titres to CO06 of the sera collected from each
dog or horse on Days −1, 9 and 14 or Days −1, 9, 14 and
21, respectively, were also measured as previously
described [15]. Briefly, the antisera were treated with
trypsin, heat and potassium metaperiodate to remove
non-specific inhibitors. Then the required final dilution
of the treated antiserum (1:10) was prepared and
adsorbed with packed chicken erythrocytes. Two-fold
dilutions of the antiserum with PBS were prepared; 25 μl
of the diluted serum was used in each well of a micro-
plate. 25 μl of virus containing 4 haemagglutination units
was added to each well, and the microplate was incu-
bated at room temperature for 30 min. Then 50 μl of
0.5% chicken erythrocytes was added to each well. The
results were read after incubation at room temperature
for 60 min. The HI antibody titres were determined by
Figure 1 Body temperatures of each dog. The horizontal dotted line
represents 39.5°C.
Table 3 Virus detection by egg culture and titre




Dog 1 Horse 1 Dog 2 Horse 2 Dog 3 Horse 3
−1 -a - - - - -
0 - - - - - -
1 - - ≤1.3 - - -
2 2.0 - 1.5 - - -
3 ≤1.0 - 2.2 - ≤1.0 -
4 - - - - ≤1.0 -
5 - - 2.8 - 1.7 -
6 - - - - - -
7 - - - - - -
8 - - - - - -
9 - - - - - -
10 - - - - - -
11 - - - - - -
12 - - - - - -
13 - - - - - -
14a - - - - - -
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ited no haemagglutination.
The dogs and horses were examined by gross path-
ology on Days 14 and 21, respectively, after the euthan-
asia. If lesions were observed by gross pathology, they
were subjected to further bacterial examinations. The
samples were aseptically trimmed and then homogenizedTable 2 Clinical scores for each animala
Days after
inoculation
Dog 1 Horse 1 Dog 2 Horse 2 Dog 3 Horse 3
−1 0 0 0 0 0 0
0 0 0 0 0 0 0
1 0 0 0 0 0.5 0
2 0 0 1.5 0 2.0 0
3 1.0 0 0.5 0 0.5 0
4 0.5 0 0.5 0 0.5 0
5 0.5 0 0 0 0.5 0
6 1.0 0 0.5 0 1.0 0
7 0 0 0.5 0 0.5 0
8 1.0 0 0.5 0 2.5 0
9 1.0 0 0.5 0 2.0 0
10 2.0 0 1.0 0 3.5 0
11 0.5 0 0.5 0 0.5 0
12 0.5 0 0 0 2.0 0
13 1.5 0 0.5 0 1.5 0
14b 0 0 0 0 1.5 0
15 Nil 0 Nil 0 Nil 0
16 Nil 0 Nil 0 Nil 0
17 Nil 0 Nil 0 Nil 0
18 Nil 0 Nil 0 Nil 0
19 Nil 0 Nil 0 Nil 0
20 Nil 0 Nil 0 Nil 0
21b Nil 0 Nil 0 Nil 0
a Animals with the same number were paired.
bThe dogs and horses were euthanized on Day 14 and 21, respectively, after
sample collection.
15 Nil - Nil - Nil -
16 Nil - Nil - Nil -
17 Nil - Nil - Nil -
18 Nil - Nil - Nil -
19 Nil - Nil - Nil -
20 Nil - Nil - Nil -
21c Nil - Nil - Nil -
a <0.7 (No CIV haemagglutination activity was detected from four eggs
inoculated with 1:10 dilution of nasal swab specimen).with nine times their volume of sterile distilled water.
Subsequently, 100 μl of each sample was inoculated onto
a blood agar plate and a MacConkey agar plate, and then
incubated aerobically for 24 h at 37°C or anaerobically
for 48 h also at 37°C. Bacterial identification was per-
formed by employing Gram staining, morphological fea-
tures, the catalase test, the oxidase test and commercial
identification test kits (API, SYSMEX).
All experimental procedures were conducted in a bio-
safety level-3 facility and approved by the Animal Care
Committee of the Equine Research Institute of the Japan
Racing Association.Table 4 HI titres of each animal
Days after
inoculation
Dog 1 Horse 1 Dog 2 Horse 2 Dog 3 Horse 3
−1 <10 <10 <10 <10 <10 <10
9 40 <10 40 <10 20 <10
14 160 <10 640 <10 320 <10
21 Nil <10 Nil <10 Nil <10
Figure 2 Lung lesions in each of the infected dogs that were
euthanized on Day 14. Arrows point to the areas of lung
consolidation.
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The rectal temperatures of the dogs are shown in Figure 1.
All the dogs began showing significant pyrexia (≥39.5°C)
on Day 2 or 3. Although Dog 2 exhibited significant pyr-
exia only for Day 2, Dogs 1 and 3 were pyrexial for six days
during this study. The clinical scores of the dogs are listed
in Table 2. All the dogs showed a range of clinical signs, in-
cluding a nasal discharge and cough after inoculation. Al-
though only Dog 2 showed a serous nasal discharge, Dogs
1 and 3 showed a mucopurulent nasal discharge for two
days and seven days respectively after inoculation. More-
over, Dog 3 was observed sneezing on Day 10 and exhib-
ited depression on Day 12. The results of virus titres of
the nasal swab extracts collected from the dogs are pre-
sented in Table 3. The viruses were isolated from the
nasal swabs collected from all the dogs for two to four
days after inoculation. All the dogs showed seroconver-
sion to CO06 in an HI test (Table 4). The gross path-
ology revealed lung consolidations that ranged from
dark red to brown (Figure 2) in all the experimental
dogs. Streptococcus equi subsp. zooepidemicus was iso-
lated from the lung consolidations of Dogs 1, 2 and 3
(2.4 × 104, 1.2 × 104 and 7.4 × 105 colony forming unit/g,
respectively). It has been reported that secondary pneu-
monia induced by Streptococcus equi subsp. zooepidemi-
cus was observed in diseased dogs during a CIV
outbreak in Iowa in the United States in 2005 [16]. Col-
lectively, these findings demonstrate that we reproducedFigure 3 Body temperatures of each horse. The horizontal dotted line rethe typical clinical features of field canine influenza ex-
perimentally infected with CIV.
Meanwhile, none of the paired horses showed any pyr-
exia (Figure 3) or other clinical signs (Table 2). No
horses presented with virus shedding (Table 3) or sero-
conversion (Table 4) in this study. No lesions were
observed in the respiratory tract including the lungs of
the horses by gross pathology. Moreover, no specific
gene of H3 subtype was detected in nasal swab speci-
mens daily collected from each horse throughout this
study by reverse transcription loop-mediated isothermal
amplification assay (See Additional file 1) [17]. Thus, we
conclude that there was no evidence suggesting the in-
fection of horses with CIV in this study.
We have previously reported the feasibility of the close
contact transmission of EIV (A/equine/Ibaraki/1/2007,
H3N8) from a diseased horse to a paired dog [11]. The
current result is opposite to that in the previous study.
One reason for this may be the difference between the
body sizes of dogs and horses. In terms of average body
weight, the dogs at 12.7 kg were more than 25 times
lighter than the horses (342 kg) at the beginning of this
study. In fact, the highest titre of each dog during this
study (range 101.7 to 102.8 EID50/200 μl, Table 3) was ap-
parently lower than those of horses inoculated with EIV
in the previous study (range 103.5 to 104.3 EID50/200 μl)
[11], although the sampling conditions (swab size and
medium volume) were admittedly different between dogs
and horses. In turn, this could result in a difference in
the total quantities of viral excretions into the air from
the dogs and horses. The other reason could be the dif-
ference between the viral features of CIV and EIV. It has
previously been reported that CO06 had reduced infect-
ivity and pathogenicity in horses compared with A/
equine/Ibaraki/1/2007 probably because of the reduction
in the ability of CO06 to bind to N-glycolylneuraminic
acid α2-3 galactose [9], which is predominantly
expressed in the horse respiratory tract [18]. This may
also contribute to the difference between the results of
the previous study [11] and the current study. It haspresents 38.8°C.
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provided no evidence of CIV infection among horses in
the United States [19]. Our findings in this study are
consistent with the phenomenon observed in the field.
Conclusions
We demonstrated experimentally that close contact be-
tween a horse and a single dog infected with CIV did
not lead to the interspecies transmission of CIV. This
may indicate that a single dog infected with CIV is not
sufficient to constitute a source of CIV infection in
horses.
Additional file
Additional file 1 Detection of viral specific gene by reverse transcription
loop-mediated isothermal amplification (RT-LAMP) assay of nasal swab
specimen collected daily from each horse.
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